cupric chloride has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdel-Mohsen, MA; Helal, MA; Toson, EA | 1 |
An, H; Cho, TM; Cho, Y; Kim, JY; Kim, YJ; Lee, N; Oh, E; Seo, JH; Sung, D | 1 |
2 other study(ies) available for cupric chloride and ER-Negative PR-Negative HER2-Negative Breast Cancer
Article | Year |
---|---|
Oncostatic treatment effect of triple negative breast cancer cell line with copper (I)-nicotinate complex.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Copper; Female; Gene Expression; Humans; Niacin; Phosphorylation; Programmed Cell Death 1 Receptor; Superoxide Dismutase; Survivin; Triple Negative Breast Neoplasms | 2019 |
Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
Topics: Animals; Anoikis; Antineoplastic Agents; Calpain; Cell Line, Tumor; Cell Movement; Cell Proliferation; Copper; Cytoskeleton; Disulfiram; Dose-Response Relationship, Drug; Enzyme Activation; Female; Focal Adhesions; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Proteolysis; Signal Transduction; Time Factors; Triple Negative Breast Neoplasms; Tumor Burden; Vimentin; Xenograft Model Antitumor Assays | 2017 |